135 related articles for article (PubMed ID: 29378908)
1. The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by Regulating
Wang L; Meng Y; Xu JJ; Zhang QY
Mol Cancer Res; 2018 May; 16(5):857-868. PubMed ID: 29378908
[TBL] [Abstract][Full Text] [Related]
2. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
Meng Y; Wang L; Xu J; Zhang Q
Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer.
Li S; Xu JJ; Zhang QY
Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121
[TBL] [Abstract][Full Text] [Related]
4. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
5. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.
Li L; Wei XH; Pan YP; Li HC; Yang H; He QH; Pang Y; Shan Y; Xiong FX; Shao GZ; Zhou RL
Oncogene; 2010 Oct; 29(43):5785-95. PubMed ID: 20711237
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.
Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL
Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708
[TBL] [Abstract][Full Text] [Related]
8. miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.
Zhang H; Qi S; Zhang T; Wang A; Liu R; Guo J; Wang Y; Xu Y
Oncotarget; 2015 Mar; 6(8):6092-104. PubMed ID: 25714029
[TBL] [Abstract][Full Text] [Related]
9. AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.
Chen C; Cai Q; He W; Lam TB; Lin J; Zhao Y; Chen X; Gu P; Huang H; Xue M; Liu H; Su F; Huang J; Zheng J; Lin T
Cell Death Dis; 2017 Oct; 8(10):e3060. PubMed ID: 28981098
[TBL] [Abstract][Full Text] [Related]
10. Autophagy, Cell Viability, and Chemoresistance Are Regulated By miR-489 in Breast Cancer.
Soni M; Patel Y; Markoutsa E; Jie C; Liu S; Xu P; Chen H
Mol Cancer Res; 2018 Sep; 16(9):1348-1360. PubMed ID: 29784669
[TBL] [Abstract][Full Text] [Related]
11. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
[TBL] [Abstract][Full Text] [Related]
12. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR.
Wang L; Meng Y; Zhang QY
BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109
[TBL] [Abstract][Full Text] [Related]
13. AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.
Chen S; Chiu SK
Mol Cell Biochem; 2015 Sep; 407(1-2):57-68. PubMed ID: 26037074
[TBL] [Abstract][Full Text] [Related]
14. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
15. LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro.
Meng F; Chen X; Song H; Lou G
Cell Physiol Biochem; 2015; 37(3):890-900. PubMed ID: 26383850
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.
Meng F; Chen X; Song H; Lou G; Fu S
Chem Biol Drug Des; 2016 Jan; 87(1):121-30. PubMed ID: 26247403
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal transmembrane protein LAPTM4B promotes autophagy and tolerance to metabolic stress in cancer cells.
Li Y; Zhang Q; Tian R; Wang Q; Zhao JJ; Iglehart JD; Wang ZC; Richardson AL
Cancer Res; 2011 Dec; 71(24):7481-9. PubMed ID: 22037872
[TBL] [Abstract][Full Text] [Related]
18. TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling.
Hou Z; Guo K; Sun X; Hu F; Chen Q; Luo X; Wang G; Hu J; Sun L
Mol Cancer; 2018 Dec; 17(1):172. PubMed ID: 30541550
[TBL] [Abstract][Full Text] [Related]
19. LAPTM4B promotes the progression of nasopharyngeal cancer.
Su Q; Luo H; Zhang M; Gao L; Zhao F
Bosn J Basic Med Sci; 2021 Jun; 21(3):305-312. PubMed ID: 32651973
[TBL] [Abstract][Full Text] [Related]
20. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression.
Kasper G; Vogel A; Klaman I; Gröne J; Petersen I; Weber B; Castaños-Vélez E; Staub E; Mennerich D
Cancer Lett; 2005 Jun; 224(1):93-103. PubMed ID: 15911104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
